Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Swantje I. Hammerschmidt"'
Autor:
Ivan Odak, Lennart Riemann, Inga Sandrock, Anne Cossmann, Gema Morillas Ramos, Swantje I. Hammerschmidt, Christiane Ritter, Michaela Friedrichsen, Ahmed Hassan, Alexandra Dopfer-Jablonka, Metodi V. Stankov, Leonie M. Weskamm, Marylyn M. Addo, Inga Ravens, Stefanie Willenzon, Anja Schimrock, Jasmin Ristenpart, Anika Janssen, Joana Barros-Martins, Gesine Hansen, Christine Falk, Georg M.N. Behrens, Reinhold Förster
Publikováno v:
EBioMedicine, Vol 99, Iss , Pp 104947- (2024)
Summary: Background: Human immune responses to COVID-19 vaccines display a large heterogeneity of induced immunity and the underlying immune mechanisms for this remain largely unknown. Methods: Using a systems biology approach, we longitudinally prof
Externí odkaz:
https://doaj.org/article/dc942db6e492430cafa301d2bcc525b7
Autor:
Georg M. N. Behrens, Joana Barros-Martins, Anne Cossmann, Gema Morillas Ramos, Metodi V. Stankov, Ivan Odak, Alexandra Dopfer-Jablonka, Laura Hetzel, Miriam Köhler, Gwendolyn Patzer, Christoph Binz, Christiane Ritter, Michaela Friedrichsen, Christian Schultze-Florey, Inga Ravens, Stefanie Willenzon, Anja Bubke, Jasmin Ristenpart, Anika Janssen, George Ssebyatika, Verena Krähling, Günter Bernhardt, Markus Hoffmann, Stefan Pöhlmann, Thomas Krey, Berislav Bošnjak, Swantje I. Hammerschmidt, Reinhold Förster
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-10 (2022)
Vaccines against SARS-CoV-2 have changed the course of the COVID-19 pandemics, but waning immunity necessitates repeated immunization. Authors here show that immunity declines faster following two doses of vector-based vaccine compared to a first dos
Externí odkaz:
https://doaj.org/article/f52b7c9a5c1744e8b2ee862e712fdd80
Autor:
Joana Barros-Martins, Swantje I. Hammerschmidt, Gema Morillas Ramos, Anne Cossmann, Laura Hetzel, Ivan Odak, Miriam Köhler, Metodi V. Stankov, Christiane Ritter, Michaela Friedrichsen, Inga Ravens, Anja Schimrock, Jasmin Ristenpart, Anika Janssen, Stefanie Willenzon, Günter Bernhardt, Ralf Lichtinghagen, Berislav Bošnjak, Georg M. N. Behrens, Reinhold Förster
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Since early 2022, various Omicron variants have dominated the SARS-CoV-2 pandemic in most countries. All Omicron variants are B-cell immune escape variants, and antibodies induced by first-generation COVID-19 vaccines or by infection with earlier SAR
Externí odkaz:
https://doaj.org/article/11b381854c5e4bc19005652544e278a1
Autor:
Ivan Odak, Christian R. Schultze-Florey, Swantje I. Hammerschmidt, Christiane Ritter, Stefanie Willenzon, Michaela Friedrichsen, Inga Ravens, Ruth Sikora, Lâle M. Bayir, Rodrigo Gutierrez Jauregui, Günter Bernhardt, Metodi V. Stankov, Anne Cossmann, Guido Hansen, Thomas Krey, Markus Cornberg, Christian Koenecke, Georg M. N. Behrens, Berislav Bošnjak, Reinhold Förster
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Evaluating long-term protection against SARS-CoV-2 variants of concern in convalescing individuals is of high clinical relevance. In this prospective study of a cohort of 46 SARS-CoV-2 patients infected with the Wuhan strain of SARS-CoV-2 we longitud
Externí odkaz:
https://doaj.org/article/cf4df2c823ac4cc7985e44f248684b3b
Autor:
Berislav Bošnjak, Ivan Odak, Joana Barros-Martins, Inga Sandrock, Swantje I. Hammerschmidt, Marc Permanyer, Gwendolyn E. Patzer, Hristo Greorgiev, Rodrigo Gutierrez Jauregui, Alina Tscherne, Jan Hendrik Schwarz, Georgia Kalodimou, George Ssebyatika, Malgorzata Ciurkiewicz, Stefanie Willenzon, Anja Bubke, Jasmin Ristenpart, Christiane Ritter, Tamara Tuchel, Christian Meyer zu Natrup, Dai-Lun Shin, Sabrina Clever, Leonard Limpinsel, Wolfgang Baumgärtner, Thomas Krey, Asisa Volz, Gerd Sutter, Reinhold Förster
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Antigen-specific tissue-resident memory T cells (Trms) and neutralizing IgA antibodies provide the most effective protection of the lungs from viral infections. To induce those essential components of lung immunity against SARS-CoV-2, we tested vario
Externí odkaz:
https://doaj.org/article/76eb9b3576254d289905045704455f62
Autor:
Swantje I. Hammerschmidt, Kathrin Werth, Michael Rothe, Melanie Galla, Marc Permanyer, Gwendolyn E. Patzer, Anja Bubke, David N. Frenk, Anton Selich, Lucas Lange, Axel Schambach, Berislav Bošnjak, Reinhold Förster
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
To present antigens to cognate T cells, dendritic cells (DCs) exploit the chemokine receptor CCR7 to travel from peripheral tissue via afferent lymphatic vessels to directly enter draining lymph nodes through the floor of the subcapsular sinus. Here,
Externí odkaz:
https://doaj.org/article/257304072d3544159c04aa87243fb8fc
Autor:
Georg M. N. Behrens, Joana Barros-Martins, Anne Cossmann, Gema Morillas Ramos, Metodi V. Stankov, Ivan Odak, Alexandra Dopfer-Jablonka, Laura Hetzel, Miriam Köhler, Gwendolyn Patzer, Christoph Binz, Christiane Ritter, Michaela Friedrichsen, Christian Schultze-Florey, Inga Ravens, Stefanie Willenzon, Anja Bubke, Jasmin Ristenpart, Anika Janssen, George Ssebyatika, Verena Krähling, Günter Bernhardt, Markus Hoffmann, Stefan Pöhlmann, Thomas Krey, Berislav Bošnjak, Swantje I. Hammerschmidt, Reinhold Förster
Publikováno v:
Nature communications. 13(1)
Heterologous prime/boost vaccination with a vector-based approach (ChAdOx-1nCov-19, ChAd) followed by an mRNA vaccine (e.g. BNT162b2, BNT) has been reported to be superior in inducing protective immunity compared to repeated application of the same v
Publikováno v:
Immunological reviewsREFERENCES. 306(1)
Dendritic cells (DCs) are crucial for the appropriate initiation of adaptive immune responses. During inflammation, DCs capture antigens, mature, and migrate to lymphoid tissues to present foreign material to naive T cells. These cells get activated
Autor:
Swantje I. Hammerschmidt, Christoph Thurm, Berislav Bošnjak, Günter Bernhardt, Annegret Reinhold, Stefanie Willenzon, Christiane Ritter, Dirk Reinhold, Burkhart Schraven, Reinhold Förster
Publikováno v:
European journal of immunology. 52(2)
Sera of vaccines were assessed by surrogate virus neutralization tests for their capacity to neutralize the SARS-CoV-2 Delta variant. Homologous prime-boost immunization with Moderna's Spikevax as well as heterologous immunization with AstraZeneca's
Autor:
null Swantje I. Hammerschmidt, null Christoph Thurm, null Berislav Bošnjak, null Günter Bernhardt, null Annegret Reinhold, null Stefanie Willenzon, null Christiane Ritter, null Dirk Reinhold, null Burkhart Schraven, null Reinhold Förster
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e18561293a8d47931473cc9a43a8323f
https://doi.org/10.1002/eji.202149645/v2/response1
https://doi.org/10.1002/eji.202149645/v2/response1